Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Ocular sarcoidosis
S Pasadhika, JT Rosenbaum - Clinics in chest medicine, 2015 - pmc.ncbi.nlm.nih.gov
Sarcoidosis is one of the leading causes of inflammatory eye disease. Ocular sarcoidosis
can involve any part of the eye and its adnexal tissues, and may cause uveitis …
can involve any part of the eye and its adnexal tissues, and may cause uveitis …
Oxidative stress and reactive oxygen species: a review of their role in ocular disease
For many years, oxidative stress arising from the ubiquitous production of reactive oxygen
species (ROS) has been implicated in the pathogenesis of various eye diseases. While …
species (ROS) has been implicated in the pathogenesis of various eye diseases. While …
Expert panel recommendations for the use of anti–tumor necrosis factor biologic agents in patients with ocular inflammatory disorders
Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α)
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …
Current concepts in the etiology and treatment of Behçet disease
C Evereklioglu - Survey of ophthalmology, 2005 - Elsevier
Behçet disease is an idiopathic, multisystem, chronic, and recurrent disease characterized
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …
by exacerbations alternating with phases of quiescence, episodic panuveitis, and …
Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients
A Arida, K Fragiadaki, E Giavri, PP Sfikakis - Seminars in arthritis and …, 2011 - Elsevier
OBJECTIVE:: Off-label use of anti-tumor necrosis factor (TNF) agents for Behçet's disease
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …
(BD) is increasing. We evaluated published data on their efficacy and safety for patients with …
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
The disorders collectively known as inflammatory bowel disease (IBD) include Crohn's
disease (CD) and ulcerative colitis (UC). CD, initially credited as having been described in …
disease (CD) and ulcerative colitis (UC). CD, initially credited as having been described in …
Anti-TNF therapy in the management of Behçet's disease—review and basis for recommendations
Behcet's disease (BD) is a multisystem, chronic-relapsing, inflammatory disorder classified
among the vasculitides [1, 2]. It has a worldwide distribution being more prevalent in the …
among the vasculitides [1, 2]. It has a worldwide distribution being more prevalent in the …
Update on the use of systemic biologic agents in the treatment of noninfectious uveitis
S Pasadhika, JT Rosenbaum - Biologics: Targets and Therapy, 2014 - Taylor & Francis
Uveitis is one of the leading causes of blindness worldwide. Noninfectious uveitis may be
associated with other systemic conditions, such as human leukocyte antigen B27-related …
associated with other systemic conditions, such as human leukocyte antigen B27-related …
Update on the therapy of Behçet disease
Z Saleh, T Arayssi - Therapeutic advances in chronic …, 2014 - journals.sagepub.com
Behçet disease is a chronic inflammatory systemic disorder, characterized by a relapsing
and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and …
and remitting course. It manifests with oral and genital ulcerations, skin lesions, uveitis, and …
Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation
PURPOSE: Anti–tumor necrosis factor α (anti–TNF-α) agents are being used increasingly in
refractory inflammatory eye diseases. We reviewed our patients on etanercept and infliximab …
refractory inflammatory eye diseases. We reviewed our patients on etanercept and infliximab …